Inhibitors of ocular neovascularization: promises and potential problems

JAMA. 2005 Mar 23;293(12):1509-13. doi: 10.1001/jama.293.12.1509.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Angiogenesis Inhibitors / therapeutic use*
  • Antibodies, Monoclonal / administration & dosage
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Aptamers, Nucleotide
  • Diabetic Retinopathy / drug therapy*
  • Humans
  • Injections
  • Macular Degeneration / drug therapy*
  • Oligonucleotides / administration & dosage
  • Oligonucleotides / therapeutic use*
  • Ranibizumab
  • Vascular Endothelial Growth Factor A / antagonists & inhibitors*

Substances

  • Angiogenesis Inhibitors
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Aptamers, Nucleotide
  • Oligonucleotides
  • Vascular Endothelial Growth Factor A
  • pegaptanib
  • Ranibizumab